Transsphenoidal Extent of Resection Study
Status: | Active, not recruiting |
---|---|
Conditions: | Brain Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 8/25/2018 |
Start Date: | February 1, 2015 |
End Date: | February 2020 |
Prospective Multicenter Cohort Study Comparing Extent of Tumor Resection Between Microscopic Transsphenoidal Surgery and Fully Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas
The purpose of this research study is to compare the extent of resection (EOR) in patients
with nonfunctioning pituitary adenomas undergoing transsphenoidal surgery using a
microsurgical technique to those patients who have undergone surgery with a fully endoscopic
technique. Another goal is to compare surgical complications, endocrine outcomes, visual
outcomes, length of surgery, length of hospital stay, and readmission rates between the two
transsphenoidal surgery techniques. This is an observational data collection study with no
experimental procedures or experimental medicines. Endonasal transsphenoidal removal of a
pituitary tumor is a unique procedure and there is little information comparing the two
surgical techniques.
with nonfunctioning pituitary adenomas undergoing transsphenoidal surgery using a
microsurgical technique to those patients who have undergone surgery with a fully endoscopic
technique. Another goal is to compare surgical complications, endocrine outcomes, visual
outcomes, length of surgery, length of hospital stay, and readmission rates between the two
transsphenoidal surgery techniques. This is an observational data collection study with no
experimental procedures or experimental medicines. Endonasal transsphenoidal removal of a
pituitary tumor is a unique procedure and there is little information comparing the two
surgical techniques.
The treatment of choice for most patients with symptomatic nonfunctioning pituitary adenomas
is transsphenoidal surgery to improve vision by decompression of the optic chiasm, to prevent
the development of endocrine dysfunction, and to treat neurological symptoms such as headache
or cranial neuropathies caused by the tumor. The most widely accepted surgical technique is
microscopic transsphenoidal surgery, in which an operating microscope is used by the surgeon
to provide surgical visualization and a nasal speculum is used to maintain the operative
corridor. [1-4] Recently, fully endoscopic transsphenoidal surgery, in which surgical
visualization is achieved using an endoscope, has been adopted by many pituitary surgeons
because the technique offers superior panoramic and angled visualization of the surgical
target and may permit greater tumor resection. [5-10] There is a vigorous debate in the
neurosurgical community about the relative merits of the microscopic and endoscopic
techniques. Proponents of the endoscopic technique argue that the superior visualization
permits more aggressive tumor resection and better preservation of the normal pituitary
gland. Proponents of the microscopic technique argue that it permits shorter operative times,
results in similar surgical outcomes, and has a lower complication rate.
Despite the adoption of fully endoscopic surgery by many surgeons, no prospective studies
have compared the extent of tumor resection (EOR) between microscopic and endoscopic
approaches. Numerous retrospective studies have established the efficacy of each approach,
but only a few studies present comparative data.[11-13] Recently, McLaughlin et al. noted
that the addition of endoscopy to microscopic pituitary surgery enhances tumor removal,
particularly in patients with tumors greater than 20 mm in diameter. [14] This study raises
the intriguing possibility that certain subgroups of patients (e.g. patients with larger
tumors) may benefit from endoscopic surgery. In patients with smaller tumors with no
cavernous sinus invasion, others have shown that the techniques achieve similar EOR. [15]
That endoscopy may permit more complete tumor resections is a testable hypothesis.
is transsphenoidal surgery to improve vision by decompression of the optic chiasm, to prevent
the development of endocrine dysfunction, and to treat neurological symptoms such as headache
or cranial neuropathies caused by the tumor. The most widely accepted surgical technique is
microscopic transsphenoidal surgery, in which an operating microscope is used by the surgeon
to provide surgical visualization and a nasal speculum is used to maintain the operative
corridor. [1-4] Recently, fully endoscopic transsphenoidal surgery, in which surgical
visualization is achieved using an endoscope, has been adopted by many pituitary surgeons
because the technique offers superior panoramic and angled visualization of the surgical
target and may permit greater tumor resection. [5-10] There is a vigorous debate in the
neurosurgical community about the relative merits of the microscopic and endoscopic
techniques. Proponents of the endoscopic technique argue that the superior visualization
permits more aggressive tumor resection and better preservation of the normal pituitary
gland. Proponents of the microscopic technique argue that it permits shorter operative times,
results in similar surgical outcomes, and has a lower complication rate.
Despite the adoption of fully endoscopic surgery by many surgeons, no prospective studies
have compared the extent of tumor resection (EOR) between microscopic and endoscopic
approaches. Numerous retrospective studies have established the efficacy of each approach,
but only a few studies present comparative data.[11-13] Recently, McLaughlin et al. noted
that the addition of endoscopy to microscopic pituitary surgery enhances tumor removal,
particularly in patients with tumors greater than 20 mm in diameter. [14] This study raises
the intriguing possibility that certain subgroups of patients (e.g. patients with larger
tumors) may benefit from endoscopic surgery. In patients with smaller tumors with no
cavernous sinus invasion, others have shown that the techniques achieve similar EOR. [15]
That endoscopy may permit more complete tumor resections is a testable hypothesis.
Inclusion Criteria:
- Patients with suspected nonfunctioning pituitary macroadenomas (≥ 1 cm) with planned
transsphenoidal surgery
- Adults (age 18-80 years)
- Medically stable for surgery
- Reasonable expectation that patient will complete study and be available for follow-up
assessments
Exclusion Criteria:
- Prisoners
- Pregnant women
- Patients with suspected functioning pituitary adenoma
- Unable to obtain MRI of the pituitary (e.g., pacemaker, anaphylaxis to gadolinium, low
GFR)
- Pituitary apoplexy
We found this trial at
7
sites
Click here to add this to my saved trials
2200 Santa Monica Blvd
Santa Monica, California 90404
Santa Monica, California 90404
(310) 582-7438
Phone: 310-315-6125
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Phoenix, Arizona 85013
Principal Investigator: Andrew S. Little, MD
Phone: 602-406-6976
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
Click here to add this to my saved trials
Click here to add this to my saved trials